The spleen and sickle cell disease: the sick(led) spleen

Area of Science:

• Hematology
• Immunology
• Pediatrics

Background:

• The spleen performs crucial immune defense and red blood cell quality control.
• Sickle cell anaemia (SCA) frequently affects the spleen early in childhood, often before 12 months.
• Progressive splenic damage in SCA leads to functional loss (hyposplenism) or atrophy (autosplenectomy).

Purpose of the Study:

• To elucidate the pathogenic sequence leading to hyposplenism in sickle cell anaemia.
• To understand the clinical manifestations and consequences of splenic injury in SCA patients.
• To determine the impact of hyposplenism on infection susceptibility and other complications in SCA.

Main Methods:

• Review of existing literature on splenic pathology in sickle cell anaemia.
• Analysis of clinical presentations including acute splenic sequestration and splenomegaly.
• Evaluation of the relationship between hyposplenism and infectious complications.

Main Results:

• Hyposplenism is prevalent in SCA children by age 12 months, progressing to autosplenectomy by age 5.
• Splenic injury is often silent but can manifest as acute splenic sequestration, a life-threatening event in infants.
• Hyposplenism significantly increases susceptibility to encapsulated bacterial infections, though prophylaxis and immunization offer protection.

Conclusions:

• Early and progressive splenic dysfunction is a hallmark of sickle cell anaemia in children.
• Hyposplenism necessitates vigilant infection prevention strategies, including penicillin prophylaxis and vaccinations.
• Further research is needed to ascertain if hyposplenism exacerbates vaso-occlusion or other circulatory issues in SCA.